Family Management Corp Tyme Technologies, Inc. Transaction History

Family Management Corp

  • $593 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$1.34 - $3.53 $187,600 - $494,200
-140,000 Closed
0 $0
Q1 2018

May 11, 2018
BUY
$2.12 - $7.0 $63,600 - $210,000
30,000 Added 27.27%
140,000 $312,000
Q4 2017

Feb 15, 2018
BUY
$3.25 - $7.3 $357,500 - $803,000
110,000
110,000 $702,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Family Management Corp Portfolio

Follow Family Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Family Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email